Chemopreventive effects of tea in prostate cancer: Green tea versus black tea

Molecular Nutrition and Food Research

Volumn 55, Issue 6, 2011, Pages 905-920

  Henning, Susanne M ^a   Wang, Piwen ^a   Heber, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Black tea; Green tea; Green tea polyphenols; Phenolic acids; Prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT; FLAVONOID; PHENOL DERIVATIVE; PLANT EXTRACT; POLYPHENOLS;

ANIMAL; CHEMISTRY; CHEMOPROPHYLAXIS; HUMAN; INTESTINE ABSORPTION; MALE; METABOLISM; PHYTOTHERAPY; PROSTATE TUMOR; REVIEW; RISK FACTOR; SPECIES DIFFERENCE; TEA; TISSUE DISTRIBUTION;

ANIMALS; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; FLAVONOIDS; HUMANS; INTESTINAL ABSORPTION; MALE; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC NEOPLASMS; RISK FACTORS; SPECIES SPECIFICITY; TEA; TISSUE DISTRIBUTION;

ANIMALIA; CAMELLIA SINENSIS;

EID: 79958045781     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000648     Document Type: Review

References (107)

1. Sharma, V., Rao, L. J., A thought on the biological activities of black tea. Crit. Rev. Food Sci. Nutr. 2009, 49, 379-404.
2. Jemal, A., Center, M. M., DeSantis, C., Ward, E. M., Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev. 2010, 19, 1893-1907.
3. Baade, P. D., Youlden, D. R., Krnjacki, L. J., International epidemiology of prostate cancer: geographical distribution and secular trends. Mol. Nutr. Food Res. 2009, 53, 171-184.
4. Kolonel, L. N., Altshuler, D., Henderson, B. E., The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat. Rev. Cancer 2004, 4, 519-527.
5. Namiki, M., Akaza, H., Lee, S. E., Song, J. M. et al., Prostate Cancer Working Group report. Jpn. J. Clin. Oncol. 2010, 40, i70-i75.
6. Jayachandran, J., Freedland, S. J., Prevention of prostate cancer: what we know and where we are going. Am. J. Mens Health 2008, 2, 178-189.
7. Siddiqui, I. A., Saleem, M., Adhami, V. M., Asim, M., Mukhtar, H., Tea beverage in chemoprevention and chemotherapy of prostate cancer. Acta Pharmacol. Sin. 2007, 28, 1392-1408.
8. Johnson, J. J., Bailey, H. H., Mukhtar, H., Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 2010, 17, 3-13.
9. Lee, A. H., Fraser, M. L., Binns, C. W., Tea, coffee and prostate cancer. Mol. Nutr. Food Res. 2009, 53, 256-265.
10. Adhami, V. M., Ahmad, N., Mukhtar, H., Molecular targets for green tea in prostate cancer prevention. J. Nutr. 2003, 133, 2417S-2424S.
11. Siddiqui, I. A., Zaman, N., Aziz, M. H., Reagan-Shaw, S. R. et al., Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis 2006, 27, 833-839.
12. Siddiqui, I. A., Raisuddin, S., Shukla, Y., Protective effects of black tea extract on testosterone induced oxidative damage in prostate. Cancer Lett. 2005, 227, 125-132.
13. Adhami, V. M., Siddiqui, I. A., Sarfaraz, S., Khwaja, S. I. et al., Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin. Cancer Res. 2009, 15, 1947-1953.
14. Harper, C. E., Patel, B. B., Wang, J., Eltoum, I. A., Lamartiniere, C. A., Epigallocatechin-3-gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action. Prostate 2007, 67, 1576-1589.
15. Zhou, J. R., Yu, L., Zhong, Y., Blackburn, G. L., Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J. Nutr. 2003, 133, 516-521.
16. Sartor, L., Pezzato, E., Dona, M., Dell'Aica, I. et al., Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model. Int. J. Cancer 2004, 112, 823-829.
17. Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D. et al., Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 1995, 92, 3439-3443.
18. Siddiqui, I. A., Shukla, Y., Adhami, V. M., Sarfaraz, S. et al., Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharm. Res. 2008, 25, 2135-2142.
19. Teichert, F., Verschoyle, R. D., Greaves, P., Thorpe, J. F. et al., Determination of 8-oxo-2'-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies. Rapid Commun. Mass Spectrom. 2009, 23, 258-266.
20. Morey Kinney S. R., Zhang, W., Pascual, M., Greally, J. M. et al., Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate. Cancer Prev. Res. 2009, 2, 1065-1075.
21. O'Sullivan, J., Sheridan, J., Mulcahy, H., Tenniswood, M., Morrissey, C., The effect of green tea on oxidative damage and tumour formation in Lobund-Wistar rats. Eur. J. Cancer Prev. 2008, 17, 489-501.
22. Kurahashi, N., Sasazuki, S., Iwasaki, M., Inoue, M., Tsugane, S., Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am. J. Epidemiol. 2008, 167, 71-77.
23. Heilbrun, L. K., Nomura, A., Stemmermann, G. N., Black tea consumption and cancer risk: a prospective study. Br. J. Cancer 1986, 54, 677-683.
24. Jian, L., Xie, L. P., Lee, A. H., Binns, C. W., Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int. J. Cancer 2004, 108, 130-135.
25. Sonoda, T., Nagata, Y., Mori, M., Miyanaga, N. et al., A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci. 2004, 95, 238-242.
26. La Vecchia, C., Negri, E., Franceschi, S., D'Avanzo, B., Boyle, P., Tea consumption and cancer risk. Nutr. Cancer 1992, 17, 27-31.
27. Villeneuve, P. J., Johnson, K. C., Kreiger, N., Mao, Y., Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 1999, 10, 355-367.
28. Kikuchi, N., Ohmori, K., Shimazu, T., Nakaya, N. et al., No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Br. J. Cancer 2006, 95, 371-373.
29. Severson, R. K., Nomura, A. M., Grove, J. S., Stemmermann, G. N., A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 1989, 49, 1857-1860.
30. Allen, N. E., Sauvaget, C., Roddam, A. W., Appleby, P. et al., A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 2004, 15, 911-920.
31. Jain, M. G., Hislop, G. T., Howe, G. R., Burch, J. D., Ghadirian, P., Alcohol and other beverage use and prostate cancer risk among Canadian men. Int. J. Cancer 1998, 78, 707-711.
32. Henning, S. M., Fajardo-Lira, C., Lee, H. W., Youssefian, A. A. et al., Catechin content of 18 teas and a green tea extract supplement correlated with the antioxidant capacity. Nutr. Cancer 2003, 45, 226-235.
33. Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., Corti, A., Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006, 66, 1234-1240.
34. McLarty, J., Bigelow, R. L., Smith, M., Elmajian, D. et al., Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev. Res. 2009, 2, 673-682.
35. Choan, E., Segal, R., Jonker, D., Malone, S. et al., A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol. Oncol. 2005, 23, 108-113.
36. Jatoi, A., Ellison, N., Burch, P. A., Sloan, J. A. et al., A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003, 97, 1442-1446.
37. Brausi, M., Rizzi, F., Bettuzzi, S., Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. Eur. Urol. 2008, 54, 472-473.
38. Lambert, J. D., Sang, S., Lu, A. Y., Yang, C. S., Metabolism of dietary polyphenols and possible interactions with drugs. Curr. Drug Metab. 2007, 8, 499-507.
39. Lu, H., Meng, X., Yang, C. S., Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab. Dispos. 2003, 31, 572-579.
40. Henning, S. M., Choo, J. J., Heber, D., Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. J. Nutr. 2008, 138, 1529S-1534S.
41. Meng, X., Lee, M. J., Li, C., Sheng, S. et al., Formation and identification of 4'-O-methyl-(-)-epigallocatechin in humans. Drug Metab. Dispos. 2001, 29, 789-793.
42. Wang, P., Aronson, W. J., Huang, M., Zhang, Y. et al., Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev. Res. 2010, 3, 985-993.
43. Henning, S. M., Aronson, W., Niu, Y., Conde, F. et al., Tea polyphenols and theaflavins are found in prostate tissue of humans and mice after green and black tea consumption. J. Nutr. 2006, 136, 1839-1843.
44. Landis-Piwowar, K. R., Wan, S. B., Wiegand, R. A., Kuhn, D. J. et al., Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. J. Cell Physiol. 2007, 213, 252-260.
45. Lambert, J. D., Lee, M. J., Lu, H., Meng, X. et al., Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J. Nutr. 2003, 133, 4172-4177.
46. Meng, X., Sang, S., Zhu, N., Lu, H. et al., Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem. Res. Toxicol. 2002, 15, 1042-1050.
47. Chen, D., Wang, C. Y., Lambert, J. D., Ai, N. et al., Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem. Pharmacol. 2005, 69, 1523-1531.
48. Fang, M., Chen, D., Yang, C. S., Dietary polyphenols may affect DNA methylation. J. Nutr. 2007, 137, 223S-228S.
49. Yegnasubramanian, S., Kowalski, J., Gonzalgo, M. L., Zahurak, M. et al., Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res. 2004, 64, 1975-1986.
50. Nakayama, M., Gonzalgo, M. L., Yegnasubramanian, S., Lin, X. et al., GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. J. Cell Biochem. 2004, 91, 540-552.
51. Gao, K., Xu, A., Krul, C., Venema, K. et al., Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3, 4-dihydroxyphenylacetic acid has antiproliferative activity. J. Nutr. 2006, 136, 52-57.
52. Mulder, T. P., van Platerink, C. J., Wijnand Schuyl, P. J., Van Amelsvoort, J. M., Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 2001, 760, 271-279.
53. van het Hof, K. H., Kivits, G. A., Weststrate, J. A., Tijburg, L. B., Bioavailability of catechins from tea: the effect of milk. Eur. J. Clin. Nutr. 1998, 52, 356-359.
54. Kyle, J. A., Morrice, P. C., McNeill, G., Duthie, G. G., Effects of infusion time and addition of milk on content and absorption of polyphenols from black tea. J. Agric. Food Chem. 2007, 55, 4889-4894.
55. Reddy, V. C., Vidya Sagar, G. V., Sreeramulu, D., Venu, L., Raghunath, M., Addition of milk does not alter the antioxidant activity of black tea. Ann. Nutr. Metab. 2005, 49, 189-195.
56. Ryan, L., Petit, S., Addition of whole, semiskimmed, and skimmed bovine milk reduces the total antioxidant capacity of black tea. Nutr. Res. 2010, 30, 14-20.
57. Neilson, A. P., Song, B. J., Sapper, T. N., Bomser, J. A., Ferruzzi, M. G., Tea catechin auto-oxidation dimers are accumulated and retained by Caco-2 human intestinal cells. Nutr. Res. 2010, 30, 327-340.
58. Neilson, A. P., Hopf, A. S., Cooper, B. R., Pereira, M. A. et al., Catechin degradation with concurrent formation of homo- and heterocatechin dimers during in vitro digestion. J. Agric. Food Chem. 2007, 55, 8941-8949.
59. Hong, J., Lu, H., Meng, X., Ryu, J. H. et al., Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 2002, 62, 7241-7246.
60. Lambert, J. D., Elias, R. J., The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch. Biochem. Biophys. 2010, 501, 65-72.
61. Na, H. K., Kim, E. H., Jung, J. H., Lee, H. H. et al., (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch. Biochem. Biophys. 2008, 476, 171-177.
62. Kobayashi, A., Kang, M. I., Watai, Y., Tong, K. I. et al., Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell Biol. 2006, 26, 221-229.
63. Surh, Y. J., Na, H. K., NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes Nutr. 2008, 2, 313-317.
64. Bostwick, D. G., Meiers, I., Shanks, J. H., Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. Hum. Pathol. 2007, 38, 1394-1401.
65. Yu, S., Khor, T. O., Cheung, K. L., Li, W. et al., Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice. PLoS One 2010, 5, e8579.
66. Frohlich, D. A., McCabe, M. T., Arnold, R. S., Day, M. L., The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis. Oncogene 2008, 27, 4353-4362.
67. Zhang, Z. M., Yang, X. Y., Yuan, J. H., Sun, Z. Y., Li, Y. Q., Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice. Chin. Med. J. 2009, 122, 1660-1665.
68. Hastak, K., Gupta, S., Ahmad, N., Agarwal, M. K. et al., Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 2003, 22, 4851-4859.
69. Chung, L. Y., Cheung, T. C., Kong, S. K., Fung, K. P. et al., Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci. 2001, 68, 1207-1214.
70. Gupta, S., Ahmad, N., Nieminen, A. L., Mukhtar, H., Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol. Appl. Pharmacol. 2000, 164, 82-90.
71. Rosenzweig, S. A., Atreya, H. S., Defining the pathway to insulin-like growth factor system targeting in cancer. Biochem. Pharmacol. 2010, 80, 1115-1124.
72. Kojima, S., Inahara, M., Suzuki, H., Ichikawa, T., Furuya, Y., Implications of insulin-like growth factor-I for prostate cancer therapies. Int. J. Urol. 2009, 16, 161-167.
73. Li, M., He, Z., Ermakova, S., Zheng, D. et al., Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 598-605.
74. Adhami, V. M., Siddiqui, I. A., Ahmad, N., Gupta, S., Mukhtar, H., Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 2004, 64, 8715-8722.
75. Palapattu, G. S., Sutcliffe, S., Bastian, P. J., Platz, E. A. et al., Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 2005, 26, 1170-1181.
76. Kramer, G., Mitteregger, D., Marberger, M., Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur. Urol. 2007, 51, 1202-1216.
77. Hsu, A., Bray, T. M., Ho, E., Anti-inflammatory activity of soy and tea in prostate cancer prevention. Exp. Biol. Med. 2010, 235, 659-667.
78. Luqman, S., Pezzuto, J. M., NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother. Res. 2010, 24, 949-963.
79. Hussain, T., Gupta, S., Adhami, V. M., Mukhtar, H., Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int. J. Cancer 2005, 113, 660-669.
80. Daniel, K. G., Kuhn, D. J., Kazi, A., Dou, Q. P., Anti-angiogenic and anti-tumor properties of proteasome inhibitors. Curr. Cancer Drug Targets 2005, 5, 529-541.
81. Huss, W. J., Hanrahan, C. F., Barrios, R. J., Simons, J. W., Greenberg, N. M., Angiogenesis and prostate cancer: identification of a molecular progression switch. Cancer Res. 2001, 61, 2736-2743.
82. Zhang, Q., Tang, X., Lu, Q., Zhang, Z. et al., Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol. Cancer Ther. 2006, 5, 1227-1238.
83. Boddy, J. L., Fox, S. B., Han, C., Campo, L. et al., The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer. Clin. Cancer Res. 2005, 11, 7658-7663.
84. Thomas, R., Kim, M. H., Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells. Biochem. Biophys. Res. Commun. 2005, 334, 543-548.
85. Sartippour, M. R., Shao, Z. M., Heber, D., Beatty, P. et al., Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J. Nutr. 2002, 132, 2307-2311.
86. Shimizu, M., Shirakami, Y., Sakai, H., Yasuda, Y. et al., (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem. Biol. Interact. 2010, 185, 247-252.
87. Katiyar, S. K., Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins. Endocr. Metab. Immune Disord. Drug Targets 2006, 6, 17-24.
88. Duhon, D., Bigelow, R. L., Coleman, D. T., Steffan, J. J. et al., The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells. Mol. Carcinog. 2010, 49, 739-749.
89. Singh, A., Settleman, J., EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29, 4741-4751.
90. Gupta, P. B., Chaffer, C. L., Weinberg, R. A., Cancer stem cells: mirage or reality? Nat. Med. 2009, 15, 1010-1012.
91. Lawson, D. A., Witte, O. N., Stem cells in prostate cancer initiation and progression. J. Clin. Invest. 2007, 117, 2044-2050.
92. Tang, S. N., Singh, C., Nall, D., Meeker, D. et al., The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J. Mol. Signal. 2010, 5, 14.
93. Rosenberg, M. T., Froehner, M., Albala, D., Miner, M. M., Biology and natural history of prostate cancer and the role of chemoprevention. Int. J. Clin. Pract. 2010, 64, 1746-1753.
94. Hiipakka, R. A., Zhang, H. Z., Dai, W., Dai, Q., Liao, S., Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols. Biochem. Pharmacol. 2002, 63, 1165-1176.
95. Niu, Y., Chang, T. M., Yeh, S., Ma, W. L. et al., Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Oncogene 2010, 29, 3593-3604.
96. Chuu, C. P., Chen, R. Y., Kokontis, J. M., Hiipakka, R. A., Liao, S., Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Lett. 2009, 275, 86-92.
97. Pezzato, E., Sartor, L., Dell'Aica, I., Dittadi, R. et al., Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate. Int. J. Cancer 2004, 112, 787-792.
98. Ren, F., Zhang, S., Mitchell, S. H., Butler, R., Young, C. Y., Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene 2000, 19, 1924-1932.
99. Figueiroa, M. S., Cesar Vieira, J. S., Leite, D. S., Filho, R. C. et al., Green tea polyphenols inhibit testosterone production in rat Leydig cells. Asian J. Androl. 2009, 11, 362-370.
100. Lee, S. C., Chan, W. K., Lee, T. W., Lam, W. H. et al., Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Nutr. Cancer 2008, 60, 483-491.
101. Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S., Mukhtar, H., Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA 2001, 98, 10350-10355.
102. Scaltriti, M., Belloni, L., Caporali, A., Davalli, P. et al., Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling. Carcinogenesis 2006, 27, 1047-1053.
103. McCarthy, S., Caporali, A., Enkemann, S., Scaltriti, M. et al., Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer. Mol. Oncol. 2007, 1, 196-204.
104. Hsu, A., Bruno, R. S., Lohr, C. V., Taylor, A. W. et al., Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFkappaB pathway in the Noble rat model. J. Nutr. Biochem. 2010, DOI: 10.1016/j.jnutbio.2010.04.006.
105. Ellison, L. F., Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur. J. Cancer Prev. 2000, 9, 125-130.
106. Kinlen, L. J., Willows, A. N., Goldblatt, P., Yudkin, J., Tea consumption and cancer. Br. J. Cancer 1988, 58, 397-401.
107. Henning, S. M., Niu, Y., Lee, N. H., Thames, G. D. et al., Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am. J. Clin. Nutr. 2004, 80, 1558-1564.